AbbVie Inc. is 179.6x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($399.47 B vs $2.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DAWN | ABBV |
|---|---|---|
| Market cap | $2.22 B | $399.47 B |
| US-listed rank | #2027 | #28 |
| Revenue (latest FY) | $158.18M | $61.16B |
| Net income (latest FY) | -$107.32B | $4.23B |
| Net margin | -67847.2% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 493 | 1,008 |
AbbVie Inc. is 179.6x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($399.47 B vs $2.22 B).
In their latest fiscal years, Day One Biopharmaceuticals, Inc. reported $158.18M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Day One Biopharmaceuticals, Inc. and AbbVie Inc., or browse the full rankings.